| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 20 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-11-22 |
4 |
B |
$5.06 |
$247,874 |
I/I |
48,987 |
17,284,913 |
2.25 |
% |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2021-11-22 |
4 |
B |
$6.34 |
$126,756 |
I/I |
20,000 |
6,164,314 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-11-29 |
4 |
B |
$5.00 |
$5,000,000 |
I/I |
1,000,000 |
18,284,913 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-15 |
4 |
B |
$4.38 |
$74,679 |
I/I |
17,050 |
18,301,963 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-16 |
4 |
B |
$4.60 |
$92,000 |
I/I |
20,000 |
18,321,963 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-17 |
4 |
B |
$4.98 |
$369,152 |
I/I |
74,127 |
18,396,090 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-20 |
4 |
B |
$4.73 |
$257,979 |
I/I |
54,541 |
18,450,631 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-28 |
4 |
B |
$4.87 |
$146,100 |
I/I |
30,000 |
18,480,631 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-29 |
4 |
B |
$4.83 |
$130,709 |
I/I |
27,062 |
18,507,693 |
2.25 |
% |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2021-12-30 |
4 |
B |
$4.35 |
$9,999,998 |
I/I |
2,298,850 |
8,463,164 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-30 |
4 |
B |
$4.95 |
$4,935 |
I/I |
997 |
18,508,690 |
2.17 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-04 |
4 |
B |
$4.93 |
$49,300 |
I/I |
10,000 |
18,518,690 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-10 |
4 |
B |
$4.34 |
$196,281 |
I/I |
45,226 |
18,563,916 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-13 |
4 |
B |
$4.03 |
$403,000 |
I/I |
100,000 |
18,663,916 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-14 |
4 |
B |
$3.89 |
$121,442 |
I/I |
31,219 |
18,695,135 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2022-01-18 |
4 |
B |
$3.94 |
$165,133 |
I/I |
41,912 |
18,737,047 |
2.25 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-02-10 |
4 |
S |
$0.35 |
$284 |
I/I |
(800) |
3,911,804 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
I/I |
4,000,000 |
7,911,804 |
1.42 |
% |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2022-04-07 |
4 |
B |
$1.79 |
$5,000,000 |
I/I |
2,793,296 |
11,256,460 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-02 |
4 |
S |
$2.55 |
$901 |
I/I |
(353) |
646,836 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-03 |
4 |
S |
$2.54 |
$6,389 |
I/I |
(2,520) |
644,316 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-04 |
4 |
S |
$2.46 |
$12,551 |
I/I |
(5,103) |
639,213 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-05 |
4 |
S |
$2.52 |
$16,894 |
I/I |
(6,696) |
632,517 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-08 |
4 |
S |
$2.64 |
$18,014 |
I/I |
(6,824) |
625,693 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-10 |
4 |
S |
$2.65 |
$21,184 |
I/I |
(8,006) |
617,687 |
0 |
% |
|
634 Records found
|
|
Page 20 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
